30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Allogene Therapeutics Inc (ALLO)

Track

Over the last 90 days, Allogene Therapeutics Inc. has seen significant insider selling, with a net value of -$293,111.16 and a net count of -2 executives. Total sales amounted to $58,581.80, with no recorded purchases. Notable transactions include sales by President and CEO David D. Chang and SVP, Finance Annie Yoshiyama.
Stock chart
Ticker: ALLO Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Yoshiyama Annie
SVP, Finance
2 sales — total 44,247 USD
Sale 21 Apr 2026
Value US$974,685.44 | Price 119.29 | Shares 16,561
Proposed sale 21 Apr 2026
Value US$349,451.79 | Price 460.93 | Shares 67,786
Proposed sale 1 Apr 2026
Value US$2,776,760.14 | Price 314.20 | Shares 14,016
Sale 31 Mar 2026
Value US$7,167.50 | Price 2.50 | Shares 2,867
Sale 16 Mar 2026
Value US$117,974.61 | Price 2.47 | Shares 47,763
Proposed sale 16 Mar 2026
Value US$117,826.97 | Price 2.47 | Shares 47,763
Sale 16 Mar 2026
Value US$11,942.45 | Price 2.47 | Shares 4,835
Proposed sale 16 Mar 2026
Value US$11,927.50 | Price 2.47 | Shares 4,835
Sale 2 Mar 2026
Value US$18,543.20 | Price 2.60 | Shares 7,132
Proposed sale 2 Mar 2026
Value US$18,541.16 | Price 2.60 | Shares 7,132
Sale 2 Feb 2026
Value US$13,059.77 | Price 1.73 | Shares 7,549
Sale 2 Feb 2026
Value US$40,304.00 | Price 1.76 | Shares 22,900
Sale 2 Feb 2026
Value US$171,484.20 | Price 1.80 | Shares 95,269
Sale 2 Feb 2026
Value US$7,167.24 | Price 1.72 | Shares 4,167
Sale 2 Feb 2026
Value US$42,241.76 | Price 1.76 | Shares 24,001
Sale 2 Feb 2026
Value US$63,189.00 | Price 1.77 | Shares 35,700
Proposed sale 2 Feb 2026
Value US$40,214.69 | Price 1.76 | Shares 22,900
Proposed sale 2 Feb 2026
Value US$42,188.96 | Price 1.76 | Shares 24,001
Proposed sale 2 Feb 2026
Value US$63,353.22 | Price 1.77 | Shares 35,700
Proposed sale 2 Feb 2026
Value US$7,177.66 | Price 1.72 | Shares 4,167
Proposed sale 2 Feb 2026
Value US$438,522.46 | Price 1.80 | Shares 243,976
Proposed sale 2 Feb 2026
Value US$29,051.64 | Price 1.73 | Shares 16,823
Sale 21 Jan 2026
Value US$40,979.64 | Price 1.56 | Shares 26,269
Proposed sale 21 Jan 2026
Value US$40,929.05 | Price 1.56 | Shares 26,269
Sale 17 Nov 2025
Value US$958.92 | Price 1.22 | Shares 786
Proposed sale 17 Nov 2025
Value US$958.94 | Price 1.22 | Shares 786
Sale 21 Oct 2025
Value US$46,168.84 | Price 1.26 | Shares 36,744
Proposed sale 21 Oct 2025
Value US$46,168.98 | Price 1.26 | Shares 36,744
Planned sale 10 Jun 2025
Value US$52,376.70 | Price 1.42 | Shares 36,885
Proposed sale 10 Jun 2025
Value US$52,391.33 | Price 1.42 | Shares 36,885
Sale 21 Apr 2025
Value US$13,537.41 | Price 1.41 | Shares 9,601
Proposed sale 21 Apr 2025
Value US$13,537.41 | Price 1.41 | Shares 9,601
Sale 14 Mar 2025
Value US$91,469.28 | Price 1.96 | Shares 46,668
Proposed sale 14 Mar 2025
Value US$91,469.28 | Price 1.96 | Shares 46,668
Sale 14 Mar 2025
Value US$10,838.80 | Price 1.98 | Shares 5,488
Proposed sale 14 Mar 2025
Value US$10,838.80 | Price 1.97 | Shares 5,488
Planned sale 18 Feb 2025
Value US$32,350.59 | Price 2.43 | Shares 13,313
Proposed sale 18 Feb 2025
Value US$32,329.09 | Price 2.43 | Shares 13,313
Sale 3 Feb 2025
Value US$7,544.53 | Price 1.73 | Shares 4,361
Proposed sale 3 Feb 2025
Value US$7,544.97 | Price 1.73 | Shares 4,361
Sale 3 Feb 2025
Value US$32,014.40 | Price 1.70 | Shares 18,832
Proposed sale 3 Feb 2025
Value US$32,014.40 | Price 1.70 | Shares 18,832
Sale 3 Feb 2025
Value US$77,285.04 | Price 1.68 | Shares 46,003
Proposed sale 3 Feb 2025
Value US$77,445.83 | Price 1.68 | Shares 46,003
Sale 3 Feb 2025
Value US$10,950.84 | Price 1.71 | Shares 6,404
Proposed sale 3 Feb 2025
Value US$10,950.84 | Price 1.71 | Shares 6,404
Sale 3 Feb 2025
Value US$25,215.66 | Price 1.71 | Shares 14,746
Proposed sale 3 Feb 2025
Value US$25,225.48 | Price 1.71 | Shares 14,746
Sale 21 Jan 2025
Value US$48,414.22 | Price 1.78 | Shares 27,199
Proposed sale 21 Jan 2025
Value US$48,498.98 | Price 1.78 | Shares 27,199
Sale 9 Dec 2024
Value US$19,916.48 | Price 2.18 | Shares 9,136
Proposed sale 9 Dec 2024
Value US$19,954.10 | Price 2.18 | Shares 9,136
Proposed sale 6 Dec 2024
Value US$21,208.00 | Price 2.30 | Shares 9,221
Sale 5 Dec 2024
Value US$19,917.36 | Price 2.16 | Shares 9,221
Proposed sale 3 Dec 2024
Value US$22,868.08 | Price 2.48 | Shares 9,221
Proposed sale 21 Oct 2024
Value US$103,500.66 | Price 2.84 | Shares 36,404
Proposed sale 21 Aug 2024
Value US$78,843.90 | Price 2.79 | Shares 28,310
Planned sale 18 Jun 2024
Value US$42,488.43 | Price 2.28 | Shares 18,641
Proposed sale 18 Jun 2024
Value US$42,488.58 | Price 2.28 | Shares 18,641
Sale 30 May 2024
Value US$26,181.12 | Price 2.34 | Shares 11,200
Proposed sale 29 May 2024
Value US$27,716.00 | Price 2.47 | Shares 11,200
Buy 16 May 2024
Value US$4,999,997.30 | Price 2.90 | Shares 1,724,137
Buy 16 May 2024
Value US$4,999,997.30 | Price 2.90 | Shares 1,724,137
Proposed sale 22 Apr 2024
Value US$60,189.64 | Price 3.47 | Shares 17,360
Proposed sale 14 Mar 2024
Value US$231,064.53 | Price 4.33 | Shares 53,393
Buy 30 Jan 2024
Value US$683.05 | Price 3.60 | Shares 190
Proposed sale 22 Jan 2024
Value US$78,375.60 | Price 3.17 | Shares 24,690
Planned sale 18 Dec 2023
Value US$50,316.82 | Price 2.70 | Shares 18,640
Proposed sale 18 Dec 2023
Value US$50,316.67 | Price 2.70 | Shares 18,640
Sale 7 Aug 2023
Value US$42,855.00 | Price 4.29 | Shares 10,000
Proposed sale 7 Aug 2023
Value US$42,855.19 | Price 4.29 | Shares 10,000
Proposed sale 28 Jun 2023
Value US$177,121.91 | Price 4.51 | Shares 39,305
Proposed sale 20 Jun 2023
Value US$354,025.75 | Price 4.85 | Shares 72,995
Proposed sale 12 Jun 2023
Value US$3,052,841.96 | Price 5.74 | Shares 531,854
Planned sale 13 Feb 2023
Value US$20,550.00 | Price 6.85 | Shares 3,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-23 2026-04-21 S Sale
2.8
Yoshiyama Annie

SVP, Finance

Officer
16,561 +11.7%
119.29
US$974,685 		16,561 +11.7% 119.29 US$974,685
2026-04-21 2026-04-21 PrS Proposed sale
2.8
Yoshiyama Annie

Officer

Officer
67,786
460.93
US$349,452 		67,786 460.93 US$349,452
2026-04-01 2026-04-01 PrS Proposed sale
2.9
Beneski Benjamin Machinas

Officer

Officer
14,016
314.20
US$2,776,760 		14,016 314.20 US$2,776,760
2026-04-02 2026-03-31 S Sale
2.9
Beneski Benjamin Machinas

SVP, Chief Technical Officer

Officer
2,867 -1.4%
2.50
US$7,168 		2,867 -1.4% 2.50 US$7,168
2026-03-18 2026-03-16 S Sale
2.6
Chang David D

President and CEO

Executive Director
47,763 -0.9%
2.47
US$117,975 		47,763 -0.9% 2.47 US$117,975
2026-03-18 2026-03-16 S Sale
2.9
Beneski Benjamin Machinas

SVP, Chief Technical Officer

Officer
4,835 -2.4%
2.47
US$11,942 		4,835 -2.4% 2.47 US$11,942
2026-03-16 2026-03-16 PrS Proposed sale
2.9
Beneski Benjamin Machinas

Officer

Officer
4,835
2.47
US$11,928 		4,835 2.47 US$11,928
2026-03-16 2026-03-16 PrS Proposed sale
2.6
Chang David D

Officer

Officer
47,763
2.47
US$117,827 		47,763 2.47 US$117,827
2026-03-04 2026-03-02 S Sale
2.9
Beneski Benjamin Machinas

SVP, Chief Technical Officer

Officer
7,132 -3.4%
2.60
US$18,543 		7,132 -3.4% 2.60 US$18,543
2026-03-02 2026-03-02 PrS Proposed sale
2.9
Beneski Benjamin Machinas

Officer

Officer
7,132
2.60
US$18,541 		7,132 2.60 US$18,541
2026-02-04 2026-02-02 S Sale
2.9
Beneski Benjamin Machinas

SVP, Chief Technical Officer

Officer
7,549 -3.5%
1.73
US$13,060 		7,549 -3.5% 1.73 US$13,060
2026-02-04 2026-02-02 S Sale
1.4
Douglas Earl Martin

SVP, General Counsel

Officer
22,900 -3.9%
1.76
US$40,304 		22,900 -3.9% 1.76 US$40,304
2026-02-04 2026-02-02 S Sale
2.6
Chang David D

President and CEO

Executive Director
95,269 -1.8%
1.80
US$171,484 		95,269 -1.8% 1.80 US$171,484
2026-02-04 2026-02-02 S Sale
2.8
Yoshiyama Annie

SVP, Finance

Officer
4,167 -3.1%
1.72
US$7,167 		4,167 -3.1% 1.72 US$7,167
2026-02-04 2026-02-02 S Sale
1.9
Parker Geoffrey M.

CHIEF FINANCIAL OFFICER

Officer
24,001 -1.9%
1.76
US$42,242 		24,001 -1.9% 1.76 US$42,242
2026-02-04 2026-02-02 S Sale
2.0
Roberts Zachary

EVP of R&D

Officer
35,700 -5.8%
1.77
US$63,189 		35,700 -5.8% 1.77 US$63,189
2026-02-02 2026-02-02 PrS Proposed sale
1.4
EARL DOUGLAS

Officer

Officer
22,900
1.76
US$40,215 		22,900 1.76 US$40,215
2026-02-02 2026-02-02 PrS Proposed sale
1.9
GEOFFREY M PARKER

Officer

Officer
24,001
1.76
US$42,189 		24,001 1.76 US$42,189
2026-02-02 2026-02-02 PrS Proposed sale
2.0
ZACHARY J ROBERTS

Officer

Officer
35,700
1.77
US$63,353 		35,700 1.77 US$63,353
2026-02-02 2026-02-02 PrS Proposed sale
2.8
ANNIE T YOSHIYAMA

Officer

Officer
4,167
1.72
US$7,178 		4,167 1.72 US$7,178
2026-02-02 2026-02-02 PrS Proposed sale
2.6
DAVID CHANG

Officer

Officer
243,976
1.80
US$438,522 		243,976 1.80 US$438,522
2026-02-02 2026-02-02 PrS Proposed sale
2.9
BENJAMIN M BENESKI

Officer

Officer
16,823
1.73
US$29,052 		16,823 1.73 US$29,052
2026-01-23 2026-01-21 S Sale
2.0
Roberts Zachary

EVP of R&D

Officer
26,269 -4.1%
1.56
US$40,980 		26,269 -4.1% 1.56 US$40,980
2026-01-21 2026-01-21 PrS Proposed sale
2.0
Roberts Zachary

Officer

Officer
26,269
1.56
US$40,929 		26,269 1.56 US$40,929
2025-11-19 2025-11-17 S Sale
2.9
Beneski Benjamin Machinas

SVP, Chief Technical Officer

Officer
786 -0.4%
1.22
US$959 		786 -0.4% 1.22 US$959
2025-11-17 2025-11-17 PrS Proposed sale
2.9
Beneski Benjamin Machinas

Officer

Officer
786
1.22
US$959 		786 1.22 US$959
2025-10-23 2025-10-21 S Sale
1.9
Parker Geoffrey M.

CHIEF FINANCIAL OFFICER

Officer
36,744 -2.8%
1.26
US$46,169 		36,744 -2.8% 1.26 US$46,169
2025-10-21 2025-10-21 PrS Proposed sale
1.9
Parker Geoffrey M.

Officer

Officer
36,744
1.26
US$46,169 		36,744 1.26 US$46,169
2025-06-12 2025-06-10 PlS Planned sale
2.7
MESSEMER DEBORAH M.
Non-Executive Director
36,885 -25.6%
1.42
US$52,377 		36,885 -25.6% 1.42 US$52,377
2025-06-10 2025-06-10 PrS Proposed sale
2.7
MESSEMER DEBORAH M.

Director

Non-Executive Director
36,885
1.42
US$52,391 		36,885 1.42 US$52,391
2025-04-23 2025-04-21 S Sale
2.8
Yoshiyama Annie

SVP, Finance

Officer
9,601 -6.8%
1.41
US$13,537 		9,601 -6.8% 1.41 US$13,537
2025-04-21 2025-04-21 PrS Proposed sale
2.8
Yoshiyama Annie

Officer

Officer
9,601
1.41
US$13,537 		9,601 1.41 US$13,537
2025-03-18 2025-03-14 S Sale
2.6
Chang David D

President and CEO

Executive Director
46,668 -0.9%
1.96
US$91,469 		46,668 -0.9% 1.96 US$91,469
2025-03-18 2025-03-14 S Sale
2.9
Beneski Benjamin Machinas

SVP, Chief Technical Officer

Officer
5,488 -2.5%
1.98
US$10,839 		5,488 -2.5% 1.98 US$10,839
2025-03-14 2025-03-14 PrS Proposed sale
2.9
Beneski Benjamin Machinas

Officer

Officer
5,488
1.97
US$10,839 		5,488 1.97 US$10,839
2025-03-14 2025-03-14 PrS Proposed sale
2.6
Chang David D

Officer

Officer
46,668
1.96
US$91,469 		46,668 1.96 US$91,469
2025-02-20 2025-02-18 PlS Planned sale
2.7
MESSEMER DEBORAH M.
Non-Executive Director
13,313 -8.4%
2.43
US$32,351 		13,313 -8.4% 2.43 US$32,351
2025-02-18 2025-02-18 PrS Proposed sale
2.7
MESSEMER DEBORAH M.

Director

Non-Executive Director
13,313
2.43
US$32,329 		13,313 2.43 US$32,329
2025-02-05 2025-02-03 S Sale
1.9
Parker Geoffrey M.

CHIEF FINANCIAL OFFICER

Officer
4,361 -0.3%
1.73
US$7,545 		4,361 -0.3% 1.73 US$7,545
2025-02-05 2025-02-03 S Sale
2.0
Roberts Zachary

EVP of R&D

Officer
18,832 -2.8%
1.70
US$32,014 		18,832 -2.8% 1.70 US$32,014
2025-02-05 2025-02-03 S Sale
2.6
Chang David D

President and CEO

Executive Director
46,003 -0.9%
1.68
US$77,285 		46,003 -0.9% 1.68 US$77,285
2025-02-05 2025-02-03 S Sale
1.4
Douglas Earl Martin

SVP, General Counsel

Officer
6,404 -1.1%
1.71
US$10,951 		6,404 -1.1% 1.71 US$10,951
2025-02-05 2025-02-03 S Sale
3.2
MOORE TIMOTHY L.

Chief Technical Officer

Officer
14,746 -5.6%
1.71
US$25,216 		14,746 -5.6% 1.71 US$25,216
2025-02-03 2025-02-03 PrS Proposed sale
2.0
Roberts Zachary

Officer

Officer
18,832
1.70
US$32,014 		18,832 1.70 US$32,014
2025-02-03 2025-02-03 PrS Proposed sale
2.6
Chang David D

Officer

Officer
46,003
1.68
US$77,446 		46,003 1.68 US$77,446
2025-02-03 2025-02-03 PrS Proposed sale
1.4
Douglas Earl Martin

Officer

Officer
6,404
1.71
US$10,951 		6,404 1.71 US$10,951
2025-02-03 2025-02-03 PrS Proposed sale
3.2
MOORE TIMOTHY L.

Officer

Officer
14,746
1.71
US$25,225 		14,746 1.71 US$25,225
2025-02-03 2025-02-03 PrS Proposed sale
1.9
Parker Geoffrey M.

Officer

Officer
4,361
1.73
US$7,545 		4,361 1.73 US$7,545
2025-01-23 2025-01-21 S Sale
2.0
Roberts Zachary

EVP of R&D

Officer
27,199 -5.3%
1.78
US$48,414 		27,199 -5.3% 1.78 US$48,414
2025-01-21 2025-01-21 PrS Proposed sale
2.0
Roberts Zachary

Officer

Officer
27,199
1.78
US$48,499 		27,199 1.78 US$48,499
2024-12-10 2024-12-09 S Sale
2.7
MESSEMER DEBORAH M.
Non-Executive Director
9,136 -5.5%
2.18
US$19,916 		9,136 -5.5% 2.18 US$19,916
2024-12-09 2024-12-09 PrS Proposed sale
2.7
MESSEMER DEBORAH M.

Director

Non-Executive Director
9,136
2.18
US$19,954 		9,136 2.18 US$19,954
2024-12-04 2024-12-06 PrS Proposed sale
2.3
Humer Franz B

Director

Non-Executive Director
9,221
2.30
US$21,208 		9,221 2.30 US$21,208
2024-12-09 2024-12-05 S Sale
2.3
Humer Franz B
Non-Executive Director
9,221 -2.9%
2.16
US$19,917 		9,221 -2.9% 2.16 US$19,917
2024-12-02 2024-12-03 PrS Proposed sale
2.3
Humer Franz B

Director

Non-Executive Director
9,221
2.48
US$22,868 		9,221 2.48 US$22,868
2024-10-21 2024-10-21 PrS Proposed sale
1.9
Parker Geoffrey M.

Officer

Officer
36,404
2.84
US$103,501 		36,404 2.84 US$103,501
2024-08-21 2024-08-21 PrS Proposed sale
1.4
Douglas Earl Martin

Officer

Officer
28,310
2.79
US$78,844 		28,310 2.79 US$78,844
2024-06-20 2024-06-18 PlS Planned sale
2.7
MESSEMER DEBORAH M.
Non-Executive Director
18,641 -10.1%
2.28
US$42,488 		18,641 -10.1% 2.28 US$42,488
2024-06-18 2024-06-18 PrS Proposed sale
2.7
MESSEMER DEBORAH M.

Director

Non-Executive Director
18,641
2.28
US$42,489 		18,641 2.28 US$42,489
2024-06-03 2024-05-30 S Sale
2.3
Humer Franz B
Non-Executive Director
11,200 -4.2%
2.34
US$26,181 		11,200 -4.2% 2.34 US$26,181
2024-05-29 2024-05-29 PrS Proposed sale
2.3
Humer Franz B

Director

Non-Executive Director
11,200
2.47
US$27,716 		11,200 2.47 US$27,716
2024-05-20 2024-05-16 B Purchase
1.7
Belldegrun Arie
Non-Executive Director
1,724,137 +inf%
2.90
US$4,999,997 		1,724,137 +inf% 2.90 US$4,999,997
2024-05-20 2024-05-16 B Purchase
1.7
Belldegrun Arie
Non-Executive Director
1,724,137 +inf%
2.90
US$4,999,997 		1,724,137 +inf% 2.90 US$4,999,997
2024-04-22 2024-04-22 PrS Proposed sale
3.2
MOORE TIMOTHY L.

Officer

Officer
17,360
3.47
US$60,190 		17,360 3.47 US$60,190
2024-03-14 2024-03-14 PrS Proposed sale
2.6
Chang David D

Officer

Officer
53,393
4.33
US$231,065 		53,393 4.33 US$231,065
2024-03-06 2024-01-30 B Purchase
1.9
Parker Geoffrey M.

CHIEF FINANCIAL OFFICER

Officer
190 +0.0%
3.60
US$683 		190 +0.0% 3.60 US$683
2024-01-22 2024-01-22 PrS Proposed sale
2.0
Roberts Zachary

Officer

Officer
24,690
3.17
US$78,376 		24,690 3.17 US$78,376
2023-12-20 2023-12-18 PlS Planned sale
2.7
MESSEMER DEBORAH M.
Non-Executive Director
18,640 -23.0%
2.70
US$50,317 		18,640 -23.0% 2.70 US$50,317
2023-12-18 2023-12-18 PrS Proposed sale
2.7
MESSEMER DEBORAH M.

Director

Non-Executive Director
18,640
2.70
US$50,317 		18,640 2.70 US$50,317
2023-08-09 2023-08-07 S Sale
2.1
Mayo Stephen
Non-Executive Director
10,000 -28.3%
4.29
US$42,855 		10,000 -28.3% 4.29 US$42,855
2023-08-07 2023-08-07 PrS Proposed sale
2.1
Mayo Stephen

Director

Non-Executive Director
10,000
4.29
US$42,855 		10,000 4.29 US$42,855
2023-06-29 2023-06-28 PrS Proposed sale
3.3
Bhavnagri Veer

Officer

Officer
39,305
4.51
US$177,122 		39,305 4.51 US$177,122
2023-06-20 2023-06-20 PrS Proposed sale
3.3
Bhavnagri Veer

Officer

Officer
72,995
4.85
US$354,026 		72,995 4.85 US$354,026
2023-06-12 2023-06-12 PrS Proposed sale
3.0
MOORE ALISON

Officer

Officer
531,854
5.74
US$3,052,842 		531,854 5.74 US$3,052,842
2023-02-14 2023-02-13 PlS Planned sale
3.3
Bhavnagri Veer

General Counsel

Officer
3,000 -0.5%
6.85
US$20,550 		3,000 -0.5% 6.85 US$20,550
Explore more

More insider trading research around Allogene Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America